Nat Hutley

Digital

Bringing genuinely transformative healthcare innovations from concept to commercial reality is becoming increasingly complex.

News

Roche is paying $700m upfront for rights to bexobrutideg, a BTK degrader that it says has potential across oncology, immunology, and neurology.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.